Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Chill Brands Group PLC (CHBRF)

Compare
0.0325
0.0000
(0.00%)
At close: April 3 at 4:00:00 PM EDT
Loading Chart for CHBRF
  • Previous Close 0.0000
  • Open 0.0325
  • Bid --
  • Ask --
  • Day's Range 0.0325 - 0.0325
  • 52 Week Range 0.0266 - 0.0325
  • Volume 1,000
  • Avg. Volume 0
  • Market Cap (intraday) 16.429M
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Apr 7, 2025 - Apr 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tinctures, as well as nicotine-free vapour products. It serves its products under the Chill.com, Zoetic, and Chill Zero brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is based in London, the United Kingdom.

chillbrandsgroup.com

7

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CHBRF

View More

Performance Overview: CHBRF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

CHBRF
0.00%
FTSE 100 (^FTSE)
3.10%

1-Year Return

CHBRF
21.90%
FTSE 100 (^FTSE)
5.65%

3-Year Return

CHBRF
45.92%
FTSE 100 (^FTSE)
11.48%

5-Year Return

CHBRF
44.05%
FTSE 100 (^FTSE)
55.60%

Compare To: CHBRF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHBRF

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    14.20M

  • Enterprise Value

    17.98M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -44.64%

  • Return on Equity (ttm)

    -2,802.21%

  • Revenue (ttm)

    146.62k

  • Net Income Avi to Common (ttm)

    -3.64M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.95M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.79M

Research Analysis: CHBRF

View More

Company Insights: CHBRF

Research Reports: CHBRF

View More

People Also Watch